YCM
PFE icon

Yorkville Capital Management’s Pfizer PFE Stock Holding History

Yorkville Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-9,110
Closed -$256K – 55
2014
Q2 		$256K Hold
9,110
– – 0.16% 42
2014
Q1 		$277K Sell
9,110
-6,724
-42% -$200K 0.21% 41
2013
Q4 		$460K Hold
15,834
– – 0.37% 37
2013
Q3 		$432K Hold
15,834
– – 0.39% 34
2013
Q2 		$421K Buy
+15,834
New +$437K 0.4% 34

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Yorkville Capital Management's PFE Position: Q3 2014 in Review

Yorkville Capital Management sold out of Pfizer (PFE) in Q3 2014, closing a stake of 9,110 shares — an estimated $256K sold.

Yorkville Capital Management first reported a position in PFE in Q2 2013 and held it in 5 quarters. The position peaked at $460K in Q4 2013. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2014.

  • Yorkville Capital Management reported no remaining Pfizer position as of Q3 2014 after selling out during the quarter.
  • Yorkville Capital Management sold 9,110 Pfizer shares in Q3 2014, an estimated $256K.
  • Yorkville Capital Management first reported a position in Pfizer in Q2 2013 and held it in 5 quarters.
  • Yorkville Capital Management's Pfizer position peaked at $460K in Q4 2013.
  • 1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2014.

Based on Yorkville Capital Management's 13F filing for Q3 2014, filed 25 Nov 2014.